ASPEN PHARMACARE HOLDINGS LIMITED - No Change Statement and Notice of Annual General Meeting 6 December 2018

No Change Statement and Notice of Annual General Meeting – 6 December 2018

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen Holdings" or "the Company")


NO CHANGE STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING –
6 DECEMBER 2018

1. POSTING OF INTEGRATED REPORT AND AGM NOTICE

Shareholders are advised that the Company’s Integrated Report for the year ended 30 June 2018 has
been finalised and that this report and the notice of the annual general meeting (“AGM”) to be held
at its Durban offices on 6 December 2018 is being posted to shareholders. The Integrated Report,
notice of AGM and the following documents have been posted online at the Company’s website
www.aspenpharma.com at the following links - https://www.aspenpharma.com/results-and-reports/
and https://www.aspenpharma.com/supplementary-documents/:

   -   Unabridged Corporate Governance Statement and reports of the Aspen Audit & Risk and
       Social & Ethics committees for the 2018 financial year; and
   -   the Annual Financial Statements for the 2018 financial year (“AFS”).

 The AFS contain no modifications to the reviewed provisional results which were published on
 SENS on 13 September 2018. The AFS were audited by PricewaterhouseCoopers Inc. Their
 unqualified report, along with an originally signed copy of the AFS, is available for inspection at
 the Company’s registered office.

 2. NOTICE OF AGM

 Notice is hereby given that the 20th annual general meeting of the shareholders of the Company will
 be held at Aspen Place, 9 Rydall Vale Park, Douglas Saunders Drive, La Lucia Ridge Office Park,
 Durban, Kwa-Zulu Natal, on Thursday, 6 December 2018 at 10:00.

 The record date on which a person must be registered as a shareholder in the register of the
 Company for purposes of being entitled to attend and participate in, and speak and vote at, the
 meeting is Friday, 30 November 2018. Accordingly, the last day to trade in order to be registered in
 the register of members of the Company and therefore be eligible to participate in and vote at the
 annual general meeting is Tuesday, 27 November 2018. Shareholders are requested, but are not
 obliged, to submit their completed forms of proxy to the Company’s transfer secretaries (Link Market
 Services) before 10:00 on Monday, 3 December 2018.

 Shareholders who, for whatever reason, experience postal delays and who do not receive the
 notice of the AGM in time to submit proxy forms to the Company’s share transfer secretaries (Link
 Market Services) are requested to access the notice of AGM and other documents referred to
 above on the Company’s website www.aspenpharma.com. A printable version of these documents
 in PDF format can also be emailed to shareholders upon request to the Company Secretary –
 rverster@aspenpharma.com or +27 31 580 8624.


3. BROAD-BASED BLACK ECONOMIC EMPOWERMENT CERTIFICATE

Shareholders are hereby notified that in accordance with the JSE Listings Requirements, the
Company's B-BBEE compliance report in terms of section 13G(2) of the Broad-Based Black
Economic Empowerment Act 53 of 2003 read with the Broad-Based Black Economic
Empowerment Act 46 of 2013, is in the process of being submitted to the BEE Commission and
will be made available on the Company’s website www.aspenpharma.com as soon as the
submission process has completed. A further announcement in this regard will be made to
shareholders.


Durban
29 October 2018

Sponsor
Investec Bank Limited

Date: 29/10/2018 05:02:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.